Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
MP0250 is a protein therapeutic that targets VEGFA, HGF, and human serum albumin, resulting in decreased downstream signaling and reduced angiogenesis, and potentially leading to decreased tumor growth (PMID: 29568363, PMID: 29228696).
|CAS Registry Number||1816305-70-0|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|